- Biotech pay analysis: 12 execs with $35M+ M&A golden parachutesA dozen biotech executives took home nearly $1 billion worth of exit packages from selling their companies, an Endpoints News analysis found. The drug industry is undergoing a historic stretch of M…Endpoints · 1mo ago↗ source
- STAT+: Pharmalittle: We’re reading about U.S. pressure on European drug prices, longer shortages, and moreA new analysis found the average drug shortage in 2025 had lasted 5.3 years, exceeding the 4.3 years seen in 2024STAT · 1mo ago↗ source
- AstraZeneca’s ‘extensive’ obesity drug push; $125M for ultrasound-aided genetic medicineNewly published data convinced AstraZeneca to conduct a sprawling late-stage program for its GLP-1 pill. Elsewhere, Bausch + Lomb will lay off 119 employees and Cartesian boosted its ‘in vivo’ cell…